Angiotech Pursues Peripheral DES Deal With Cook, Boston Scientific
This article was originally published in The Pink Sheet Daily
Executive SummaryBoston Scientific, Cook and Angiotech are close to finalizing a three-way pact for development of peripheral drug-eluting stents. The deal would allow Cook and Boston Scientific to use paclitaxel for the peripheral stents.
You may also be interested in...
Device Week, 12 December 2019 – Global Insulin Pump Market Will Face Fierce Rivalry Among Major Players In 2020
In this edition of Device Week, Medtech Insight's deputy editor Reed Miller chats with managing editor Marion Webb about her latest in-depth Market Intel story, the first part of a two-part series focusing on the competitive landscape of the global insulin pump market.
The physician who led the first-in-human robotic-assisted neurovascular intervention with Corindus’ CorPath GRX system believes the technology could revolutionize neurovascular intervention by allowing a centralized interventional team to remotely treat patients.
R&D Roundup, November 2019: LimFlow Starts Pivotal Trial Of Peripheral Shunt; Conservative Coronary Treatment Matches Intervention In Trial
An overview of November’s 10 most-read Medtech Insight articles on topics related to research and development of new medical technology.